# Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma

> **NCT05135832** · NA · UNKNOWN · sponsor: **Herlev and Gentofte Hospital** · enrollment: 174 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma
- Kidney Cancer
- Kidney Neoplasm
- Urologic Cancer
- Urologic Neoplasms
- Advanced Renal Cell Carcinoma

## Interventions

- **DEVICE:** Electronic patient-reported outcomes regarding symptoms and health-related quality of life

## Key facts

- **NCT ID:** NCT05135832
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-13
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135832, "Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05135832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*